OdysseaBio
Professional Services • 
Montreal, Quebec, Canada • 1-10 Employees
Company overview
| Headquarters | Montreal, Quebec, Canada |
| Website | |
| NAICS | 54 |
| Keywords | Women'S Health, Strategic Communications, Cardiovascular Disease, Emerging Technologies, Medical Communication, Conference Materials, Clinical Data, Hematology And Oncology, Cell And Gene Therapies, Business/Investment Decks, Fda Reports/Data Summaries, Innovative Therapies, Patient-Facing Materials, Preclinical Data, Publication Summaries, Scientific Narratives |
| Founded | 2025 |
| Employees | 1-10 |
| Socials |
Key Contact at OdysseaBio
Deborah Maret
Co-Founder | Transforming complex science into narratives that de-risk high-stakes decisions
OdysseaBio Email Formats
OdysseaBio uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@odysseabio.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@odysseabio.com | 66.7% |
{first initial}.{last name} | j.doe@odysseabio.com | 33.3% |
About OdysseaBio
OdysseaBio partners with leadership teams in biotech, pharma, advocacy, and healthcare decision-makers to de-risk complex scientific communication by transforming data into clear, actionable narratives that build trust and drive confident decisions. We engage directly with teams to provide flexible, high-impact strategic guidance tailored to the unique needs of each project. From refining messaging for critical milestones to guiding multi-phase strategic initiatives, our approach ensures clarity, alignment, and confidence across every stage of the product lifecycle: discovery, clinical development, commercial preparation, and post-market communication. Our Services - Advisory sessions to clarify messaging strategy and priorities - Custom narrative development that transforms complex science into compelling, credible stories - Strategic guidance tailored to your objectives, timeline, and stage of development We partner with teams navigating fundraising, partnerships, product launches, medical engagement, and advocacy initiatives, ensuring messaging resonates with investors, healthcare decision-makers, and advocacy communities alike. With expertise spanning preclinical research through clinical development and post-market activities, OdysseaBio combines scientific depth with strategic communication insight to reduce risk, transform complexity into clarity, and help teams move innovation forward. 📩 Learn more at odysseabio.com or contact us at innovate@odysseabio.com to explore advisory sessions or custom narrative development.
OdysseaBio revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Professional Services industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
OdysseaBio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
OdysseaBio has never raised funding before.
United States
France
Belgium
Frequently asked questions
4.8
40,000 users
